The development of new drugs is an increasingly costly and technically complicated regulatory process. the “Pharmaco-Imagery and Theranostic Agents” project, which relies on medical imaging, is part of this framework as it aims to foster innovation in medicine in order to quickly move from preclinical developments to the clinic.